Where they hold approval

Firms where this individual holds — or has held — an FCA-approved role.

    • SMF29 Limited scope function (limited scope SMCR firms only) (since 28 Apr 2023)
    • SMF16 Compliance Oversight (since 9 Dec 2019)
    • SMF3 Executive Director (since 9 Dec 2019)
    • SMF17 Money Laundering Reporting Officer (MLRO) (since 9 Dec 2019)
    • Responsible for Insurance Distribution (since 1 Oct 2018)
    • Responsibility for MCD Intermediation (since 29 Mar 2017)
    • CF1 Director (AR) (since 5 Aug 2010)
    • [FCA CF] Client dealing (9 Dec 2019 to 23 Apr 2025)
    • [FCA CF] Functions requiring qualifications (9 Dec 2019 to 23 Apr 2025)
    • CF30 Customer (1 Nov 2007 to 28 Apr 2025)
    • CF1 Director (29 Nov 2006 to 8 Dec 2019)
    • CF8 Apportionment and Oversight (29 Nov 2006 to 31 Mar 2009)
    • Responsible for Insurance Mediation (29 Nov 2006 to 30 Sep 2018)
    • CF11 Money Laundering Reporting (29 Nov 2006 to 8 Dec 2019)
    • CF10 Compliance Oversight (29 Nov 2006 to 8 Dec 2019)
    • CF21 Investment Adviser (29 Nov 2006 to 31 Oct 2007)
    • (2)Employed By (since 27 Mar 2018)
  • Medical & Executive Financial Services (no longer approved here)

    FRN 165731

    • CF21 Investment Adviser (28 Jul 2004 to 22 Dec 2006)

Recent activity

Updates to this individual's record on the FCA register.

No changes recorded yet.